GlassScriptPhysician profile
Joseph Wieck
NPI 1750354221
$2,975.14
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,260 · 2020: $1,625 · 2021: $90.24.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,950.93 | 2019-2020 | |
| Smith+Nephew, INC. | $312.61 | 2019 | |
| Ferring Pharmaceuticals INC. | $121.75 | 2019 | |
| Trimed, INC. | $110.81 | 2020 | |
| Motive Health, INC. | $81.63 | 2019 | |
| Flower Orthopedics Coporation | $69.84 | 2021 | |
| Amgen INC. | $60.19 | 2019 | |
| Orthogenrx INC. | $50.83 | 2019 | |
| Abbott Laboratories | $48.49 | 2019 | |
| Skeletal Dynamics INC | $36.00 | 2019 | |
| Heraeus Medical, LLC. | $20.40 | 2021 | |
| Orthofix Medical, INC. | $16.53 | 2019 | |
| Ethicon US, LLC | $16.13 | 2019 | |
| Zimmer Biomet Holdings, INC. | $14.25 | 2019 | |
| Bioventus LLC | $14.21 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $13.88 | 2020 | |
| Depuy Synthes Sales INC. | $13.29 | 2019 | |
| Radius Health, INC. | $11.71 | 2019 | |
| Arteriocyte Medical Systems, INC. | $11.66 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Wieck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.